血清尿酸与性结肠炎和克罗恩病风险之间的关系:一个前性队列研究
Yijing Tie1,2, Peng Xie3,4, Kuan Li3,4
1Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, 510515, Guangdong, China.
European journal of medical research
|February 12, 2026
概括
血清尿酸 (SUA) 水平较低会增加性结肠炎 (UC) 的风险,而高水平的SUA会增加克罗恩氏病的风险.
科学领域:
- 胃肠病学和肝病学
- 代谢和内分泌疾病
- 流行病学和公共卫生.
背景情况:
- 血清尿酸 (SUA) 水平与各种疾病有关,可能影响炎症过程.
- 有限的流行病学数据存在于SUA水平与性结肠炎 (UC) 和克罗恩病 (CD) 风险之间的关联.
研究的目的:
- 调查血清尿酸水平 (SUA) 与性结肠炎 (UC) 和克罗恩病 (CD) 的发生率之间的关系.
- 探索SUA在UC和CD病原发生过程中的潜在差异性作用.
主要方法:
- 从2006年到2010年,一项涉及438,155名英国生物库参与者的大型队列研究进行了跟踪.
- 在平均12.6年的随访期间诊断了1904例UC和913例CD病例.
- 用考克斯回归和受限立方线分类的SUA水平被分类为特定性别的四分位数.
主要成果:
- 较低的SUA水平 (Q1,<4.0 mg/dL) 与UC风险增加显著相关 (HR=1.27-1.30).
- 较高的SUA水平 (Q6,≥8.0 mg/dL) 与CD风险增加显著相关 (HR=1.50).
- 亚组分析显示,男性的UC和女性的CD,以及老年人,超重个体,饮酒者和从不吸烟者之间的关联.
结论:
- 这项研究表明,血清尿酸 (SUA) 水平可能充当UC和CD的差异性风险因素.
- 低的SUA与更高的UC风险有关,而高的SUA与更高的CD风险有关.
- 这些发现为SUA在这些炎症性肠道疾病的发病过程中的独特作用提供了新的见解.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
1.4K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
1.4K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
1.1K
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
1.1K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.4K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.4K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease II: Ulcerative Colitis
61
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
61


